Navigation Links
IR BioSciences Announces Promising Data from Study of Its Compound,Homspera

Data Suggests Homspera Shows Promise As an Adjuvant for Vaccines against Avian Flu and Other Viruses

SCOTTSDALE, Ariz., May 07, 2007 /PRNewswire-FirstCall/ -- IR BioSciences Holdings, Inc. announced today that preliminary data from its influenza vaccine adjuvant study being performed in conjunction with GenPhar Inc. indicates Homspera elevates host immune responsiveness above that induced by vaccine alone system. These results are from an ongoing study, and are a strong indication that Homspera may demonstrate adjuvant capabilities, and thus be capable of augmenting host immune system responsiveness to vaccines for diseases such as pandemic avian influenza, seasonal influenza, and perhaps others for which vaccines exist or are under development.

Adjuvants are common additions to vaccine formulations, as they enable the vaccine to induce a strong immune reaction in vaccinated individuals, helping to ensure adequate immunological protection.

The Homspera studies, being carried out by GenPhar, examine the impact of vaccination with pieces of influenza viruses (a current H5N1 "avian influenza" strain and from the 1918 Spanish Influenza virus). A fear of many scientists and public health officials is that the current avian influenza endemic to Southeast Asia may mutate sufficiently to become more easily transmitted among humans, yet maintain its highly pathogenic nature. Such an event, centered on the virus currently exhibiting mortality in infected humans of approximately 50%, can trigger a rapid global spread of highly pathogenic virus with disastrous consequences.

Vaccines against avian influenza are not available in volumes needed to inoculate a significant percentage of the world's population. Similarly, the most effective prophylactic or therapeutic drug, oseltamivir (Tamiflu(R), Roche), is reportedly not being stockpiled in amounts adequate to provide protection to the at-risk population.
'"/>




Page: 1 2 3 4

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
5. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
6. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
7. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
8. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- Today leading web ... new data ranking Pharmaceutical web sites for usability, engagement, ... User Experience Cloud platform, which compares how people experience ... the web. The top three performers are ... people overall. The bottom performers have usability problems, lack ...
(Date:6/19/2013)... 2013  Omnicell, Inc. (NASDAQ: OMCL ... management solutions and analytics software for healthcare facilities, ... one overall pharmacy equipment vendor in the KLAS ... leading independent healthcare research firm, compared the performance ... annual rankings. Omnicell also received the prestigious "Best ...
(Date:6/19/2013)... -- It may seem like an odd pairing: an oral growth ... were two of the most talked about topics at ENDO ... Expo that just convened in San Francisco ... of the top internal medicine experts in the world is ... can not only save lives, but help people feel and ...
Breaking Medicine Technology:Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4
... Cancer Awareness Month is coming to an end, smart women know ... What,s more, women age 25 and older now have a ... Based on the same science as the PAP test for ... for non-hereditary breast cancer. HALO can help identify women at ...
... , AUSTIN, Texas, Oct. 28 Rules-Based Medicine ... announced the launch of CardiovascularMAP, a research tool ... the treatment of cardiovascular disease (CVD.) Designed in ... the 50-biomarker panel combines biomarkers most commonly associated ...
Cached Medicine Technology:Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women 2Breast Health is a Year-Round Priority: New Technology Identifies Risk of Breast Cancer in Younger Women 3Rules-Based Medicine Introduces CardiovascularMAP(TM) Multiplex Biomarker Panel to Aid CVD Drug Development 2Rules-Based Medicine Introduces CardiovascularMAP(TM) Multiplex Biomarker Panel to Aid CVD Drug Development 3
(Date:6/19/2013)... Kleritec, Inc. announced the addition of ... http://www.kleritec.com . In the recent expansion Kleritec ... packages for pre-school and day care providers. The company ... aid teachers across the United States the ability to ... Included in the art and activities packages is all ...
(Date:6/19/2013)... Today, Zane Benefits, Inc. published new ... Zane Benefits, which provides comprehensive and flexible alternatives to ... defined contribution and health reimbursement arrangement ... part of the Affordable Care Act (ACA), health insurance ... through new state health insurance exchanges. , Most importantly, ...
(Date:6/19/2013)... York, New York (PRWEB) June 19, 2013 ... pancreatitis and pancreatic cancer continue to mount in courts ... U.S. Food & Drug Administration (FDA) recently held a ... diabetes drugs known as incretin mimetics. According to ... seek additional data from the makers of Januvia and ...
(Date:6/19/2013)... medicine and trauma surgery have had a significant ... immediately after major injuries, including burns. Patients ... now are at greatest risk from infections ... sepsis or from inflammation-induced multiorgan failure. ... (MGH) investigators that measures the movement of key ...
(Date:6/19/2013)... online edition of the journal Nature , a ... California, San Diego School of Medicine visually monitored the ... occurs in zebrafish after cardiac ventricular injury. Their ... heart are more plastic, or capable of transformation into ... the research reveals a novel potential source of cells ...
Breaking Medicine News(10 mins):Health News:Kleritec Announces Addition of Educational Products. 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 2Health News:Januvia Lawsuit News: Bernstein Liebhard LLP Comments on Recent FDA Meeting to Discuss Safety of Januvia and Other Incretin Mimetics 3Health News:Restoring appropriate movement to immune cells may save seriously burned patients 2Health News:Restoring appropriate movement to immune cells may save seriously burned patients 3Health News:Fate of the heart: Researchers track cellular events leading to cardiac regeneration 2
... ... today was named to receive the 2009 Nobel Prize in Physiology or Medicine. Blackburn shares ... W. Szostak of Harvard Medical School. , ... San Francisco, CA (Vocus) October 5, 2009 -- Molecular biologist Elizabeth H. Blackburn, ...
... Trapeze Networks, a Belden Brand (NYSE: BDC ), ... goal of extending the company,s leadership in the international ... on three strategies: It will increase the number ... and residential care facilities, help Trapeze Networks, cadre of ...
... Children in hardest-hit areas remain at risk, warns World Vision ... help children recover , - Aid agency calls on Indonesian ... , PADANG, Indonesia, Oct. 5 As schoolchildren in Indonesia,s ... aid group World Vision says these thousands of children affected ...
... BCBSNC,s annual flu shot ... ... it to the flu? Get a flu shot . That,s the message Blue Cross and ... Flu Campaign . , , , , ,As part of the campaign, BCBSNC will cover the seasonal ...
... , ... Disability insurance provider Set for Life Insurance ... website www.setforlifeinsurance.com . The website is a refreshing break from ... blog, and custom artwork and life insurance quotes. Set for Life ...
... child will be on his/her way to the hospital to be ... day in this country.* Now, one of the largest studies ever ... Nationwide Children,s Hospital and the results are mixed: while overall injuries ... risk. Lily McKinney has always loved spending time in the ...
Cached Medicine News:Health News:UCSF Scientist Receives Nobel Prize in Physiology or Medicine 2Health News:UCSF Scientist Receives Nobel Prize in Physiology or Medicine 3Health News:UCSF Scientist Receives Nobel Prize in Physiology or Medicine 4Health News:Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market 2Health News:As Schools Reopen in Indonesia, World Vision Says Children's Basic Needs Still Not Being Met 2Health News:BCBSNC Promotes Seasonal Flu Shots and Waives Cost to Customers for H1N1 Vaccine 2Health News:BCBSNC Promotes Seasonal Flu Shots and Waives Cost to Customers for H1N1 Vaccine 3Health News:BCBSNC Promotes Seasonal Flu Shots and Waives Cost to Customers for H1N1 Vaccine 4Health News:New Website for Disability Insurance Launched by Set for Life Insurance by KF Financial 2Health News:Child burn injuries down significantly 2Health News:Child burn injuries down significantly 3
... is a modular external fixation system designed ... of clinical needs. Originally marketed in Europe ... successful 20 year history of clinical use ... the principles of the Ilizarov technique begun ...
... tonometer is an easy-to-use, hand-held instrument ... strongly with Goldmann tonometry. TONO-PEN AVIA ... advanced electronic measurement technology that enables ... IOP measurements with minimal training. TONO-PEN ...
... models of Thermo Scientific Finnpipette Dispenser cover ... mL with very high consistency, precision and ... all components. The Finnpipette Dispenser range is ... Scientific Finnpipette manual liquid handling products, offering ...
... The Invisio Digital Flexible Ureteroscope (DUR-D) ... from the proven durable, market leading ... also the first device utilizing Gyrus ... mm Complementary Metal Oxide Semi-Conductor (CMOS) ...
Medicine Products: